Generic Product News

MAY 17, 2013

Oxymorphone Hydrochloride Tablets, CII

Marketed by: Teva Pharmaceuticals
Compare to: Opana Tablets (Endo Pharmaceuticals)
Indication: Teva Pharmaceuticals announced the introduction and availability of oxymorphone hydrochloride tablets, CII. It is AB rated and bioequivalent to Endo Pharmaceuticals’ Opana. It is indicated for the relief of moderate to severe acute pain where the use of an opioid is appropriate. The tablets should be administered on an empty stomach, at least 1 hour prior to or 2 hours after eating.
Dosage Form: Tablets: 5 mg, 10 mg
For More Information:

Marketed by: Sandoz
Compare to: Ortho-Cyclen (Janssen Pharmaceuticals)
Indication: Sandoz announced the FDA approval of Estarylla (norgestimate and ethinyl estradiol tablets), a generic equivalent of the oral contraceptive Ortho-Cyclen. It is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Sandoz is marketing Estarylla in dosage regimens identical to that of the originator product, and it must be taken exactly as directed at intervals not to exceed 24 hours.
Dosage Form: Tablets: 21 containing 0.25 mg norgestimate/0.035 mg ethinyl estradiol, 7 inactive tablets
For More Information:

Buprenorphine HCL and Naloxone HCL Dihydrate SL Tablets
Marketed by: Actavis, Inc
Compare to: Suboxone (Reckitt Benckiser)
Indication: Actavis, Inc, has received approval from the FDA on its Abbreviated New Drug Application for buprenorphine HCl and naloxone HCl dihydrate tablets, the generic equivalent to Reckitt Benckiser Healthcare’s Suboxone. It is indicated for the maintenance treatment of opioid dependence. Actavis intends to begin shipping buprenorphine HCL and naloxone HCL hydrate SL tablets immediately.
Dosage Form: Tablets: 2 mg/0.5 mg, 8 mg/2 mg
For More Information:

Entacapone Tablets
Marketed by: Wockhardt
Compare to: Comtan (Orion Corporation and Novartis)
Indication: Pharmaceutical and biotechnology company Wockhardt has received FDA approval for a generic version of Comtan (entacapone). The entacapone tablets are available in a 200-mg formulation. Entacapone tablets are indicated for the treatment of idiopathic Parkinson’s disease as an adjunct to levodopa and carbidopa therapy in patients who experience the signs and symptoms of end-of-dose “wearing-off.”
Dosage Form: Tablets: 200 mg
For More Information:


Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?

Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.